Rhodium-Catalyzed Asymmetric Reductive Hydroformylation of α-Substituted Enamides

被引:3
作者
Zhu, Yuxin [1 ]
Zhang, Yuchen [2 ]
He, Dongyang [1 ]
Yang, He [1 ]
Xue, Xiao-Song [2 ,3 ]
Tang, Wenjun [1 ,3 ]
机构
[1] Univ Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Chem Biol, Shanghai 200032, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Fluorine & Nitrogen Chem & Adv Mat, Shanghai 200032, Peoples R China
[3] Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Chem & Mat Sci, Hangzhou 310024, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
ENANTIOSELECTIVE HYDROFORMYLATION; MARAVIROC UK-427,857; LIGANDS; DESIGN; ROUTE;
D O I
10.1021/jacs.4c13770
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Chiral gamma-amino alcohols are prevalent structural motifs in natural products and bioactive compounds. Nevertheless, efficient and atom-economical synthetic methods toward enantiomerically enriched gamma-amino alcohols are still lacking. In this study, a highly enantioselective rhodium-catalyzed reductive hydroformylation of readily available alpha-substituted enamides is developed, providing a series of pharmaceutically valuable chiral 1,3-amino alcohols in good yields and excellent enantioselectivities in a single step. The development of the 4,4 '-bisarylamino-substituted BIBOP ligand is crucial for the success of this transformation. DFT calculations and experimental data have revealed the importance of hydrogen bonding between the N-H group in the structure of TFPNH-BIBOP and the enamide carbonyl group in promoting both high enantioselectivity and reactivity. This method has enabled the concise synthesis of several chiral pharmaceutical intermediates including a single-step synthesis of the key chiral intermediate of maraviroc.
引用
收藏
页码:33249 / 33257
页数:9
相关论文
共 28 条
[1]   Discovery of 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases [J].
Addie, Matt ;
Ballard, Peter ;
Buttar, David ;
Crafter, Claire ;
Currie, Gordon ;
Davies, Barry R. ;
Debreczeni, Judit ;
Dry, Hannah ;
Dudley, Philippa ;
Greenwood, Ryan ;
Johnson, Paul D. ;
Kettle, Jason G. ;
Lane, Clare ;
Lamont, Gillian ;
Leach, Andrew ;
Luke, Richard W. A. ;
Morris, Jeff ;
Ogilvie, Donald ;
Page, Ken ;
Pass, Martin ;
Pearson, Stuart ;
Ruston, Linette .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (05) :2059-2073
[2]   ASYMMETRIC HYDROFORMYLATION [J].
AGBOSSOU, F ;
CARPENTIER, JF ;
MORTREAUX, A .
CHEMICAL REVIEWS, 1995, 95 (07) :2485-2506
[3]   Process Research and Scale-up of a Commercialisable Route to Maraviroc (UK-427,857), a CCR-5 Receptor Antagonist [J].
Ahman, Jens ;
Birch, Melissa ;
Haycock-Lewandowski, Sarah J. ;
Long, James ;
Wilder, Alexander .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2008, 12 (06) :1104-1113
[4]   Hydroformylation of alkenes: An industrial view of the status and importance [J].
Bohnen, HW ;
Cornils, B .
ADVANCES IN CATALYSIS, VOL 47, 2002, 47 :1-64
[5]   THE ASYMMETRIC HYDROFORMYLATION IN THE SYNTHESIS OF PHARMACEUTICALS [J].
BOTTEGHI, C ;
PAGANELLI, S ;
SCHIONATO, A ;
MARCHETTI, M .
CHIRALITY, 1991, 3 (04) :355-369
[6]   Recent Developments in the Scope, Practicality, and Mechanistic Understanding of Enantioselective Hydroformylation [J].
Brezny, Anna C. ;
Landis, Clark R. .
ACCOUNTS OF CHEMICAL RESEARCH, 2018, 51 (09) :2344-2354
[7]  
Cornils B., 2017, Applied Homogeneous Catalysis with Organometallic Compounds, P23, DOI DOI 10.1002/9783527651733.CH2
[8]   Principles and Applications of Enantioselective Hydroformylation of Terminal Disubstituted Alkenes [J].
Deng, Yuchao ;
Wang, Hui ;
Sun, Yuhan ;
Wang, Xiao .
ACS Catalysis, 2015, 5 (11) :6828-6837
[9]   Recent advances in Rh-catalyzed asymmetric hydroformylation using phosphite ligands [J].
Diéguez, M ;
Pàmies, O ;
Claver, C .
TETRAHEDRON-ASYMMETRY, 2004, 15 (14) :2113-2122
[10]  
Frisch M. J., 2016, GAUSSION 16 REVISION